Marshall Wace Portfolio holdings
AUM
$84.1B
1-Year Return
27.54%
This Quarter Return
+4.81%
1 Year Return
+27.54%
3 Year Return
+105.03%
5 Year Return
+179.94%
10 Year Return
+445.45%
AUM
$79.6B
AUM Growth
+$2.61B
(+3.4%)
Cap. Flow
+$163M
Cap. Flow
% of AUM
0.21%
Top 10 Holdings %
Top 10 Hldgs %
36.08%
Holding
2,970
New
646
Increased
879
Reduced
761
Closed
561
Top Buys
| 1 |
Apple
AAPL
|
+$1.13B |
| 2 |
UnitedHealth
UNH
|
+$832M |
| 3 |
Uber
UBER
|
+$360M |
| 4 |
Boeing
BA
|
+$352M |
| 5 |
Netflix
NFLX
|
+$333M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$680M |
| 3 |
Meta Platforms (Facebook)
META
|
+$642M |
| 4 |
Broadcom
AVGO
|
+$452M |
| 5 |
GE Vernova
GEV
|
+$439M |
Sector Composition
| 1 | Technology | 21.24% |
| 2 | Consumer Discretionary | 15.59% |
| 3 | Healthcare | 13.1% |
| 4 | Financials | 8.67% |
| 5 | Industrials | 6.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1651
TripAdvisor
TRIP
$2.06B
| $848K | ﹤0.01% |
57,394
-535,426
| -90% | -$7.91M |
|
1652
Bentley Systems
BSY
$16.1B
| $846K | ﹤0.01% |
18,125
-35,115
| -66% | -$1.64M |
|
1653
Fate Therapeutics
FATE
$111M
| $846K | ﹤0.01% |
+512,641
| New | +$846K |
|
1654
Immunocore
IMCR
$1.78B
| $844K | ﹤0.01% |
28,610
-170,833
| -86% | -$5.04M |
|
|
OPI
1655
Office Properties Income Trust
OPI
$40.8M
| $842K | ﹤0.01% |
841,993
+487,958
| +138% | +$488K |
|
1656
iShares MSCI Sweden ETF
EWD
$326M
| $842K | ﹤0.01% |
+22,548
| New | +$842K |
|
1657
Afya
AFYA
$1.42B
| $841K | ﹤0.01% |
52,949
-178,597
| -77% | -$2.84M |
|
1658
Ondas Holdings
ONDS
$2.14B
| $831K | ﹤0.01% |
+324,460
| New | +$831K |
|
1659
Safety Insurance
SAFT
$1.1B
| $831K | ﹤0.01% |
+10,079
| New | +$831K |
|
1660
Copel
ELP
$6.92B
| $828K | ﹤0.01% |
139,551
+127,482
| +1,056% | +$756K |
|
1661
Inhibrx
INBX
$399M
| $825K | ﹤0.01% |
53,586
-37,061
| -41% | -$571K |
|
1662
MIND Technology
MIND
$65.3M
| $825K | ﹤0.01% |
+103,907
| New | +$825K |
|
1663
Riskified
RSKD
$721M
| $823K | ﹤0.01% |
+173,952
| New | +$823K |
|
|
NCTY
1664
The9 Ltd
NCTY
$145M
| $823K | ﹤0.01% |
+56,583
| New | +$823K |
|
1665
Capricor Therapeutics
CAPR
$291M
| $818K | ﹤0.01% |
+59,303
| New | +$818K |
|
1666
Manhattan Associates
MANH
$13.1B
| $816K | ﹤0.01% |
+3,019
| New | +$816K |
|
1667
First United
FUNC
$239M
| $814K | ﹤0.01% |
24,146
+16,574
| +219% | +$559K |
|
1668
Gevo
GEVO
$404M
| $812K | ﹤0.01% |
+388,428
| New | +$812K |
|
|
AIRJ
1669
Montana Technologies Corp
AIRJ
$281M
| $811K | ﹤0.01% |
+101,856
| New | +$811K |
|
|
TSVT
1670
DELISTED
2seventy bio
TSVT
| $810K | ﹤0.01% |
275,536
-193,347
| -41% | -$568K |
|
1671
Viking Therapeutics
VKTX
$2.79B
| $809K | ﹤0.01% |
20,114
+2,256
| +13% | +$90.8K |
|
|
CBLL
1672
CeriBell, Inc. Common Stock
CBLL
$424M
| $808K | ﹤0.01% |
+31,215
| New | +$808K |
|
1673
Orion Group Holdings
ORN
$299M
| $805K | ﹤0.01% |
+109,786
| New | +$805K |
|
1674
Pacira BioSciences
PCRX
$1.22B
| $803K | ﹤0.01% |
42,613
-482,336
| -92% | -$9.09M |
|
1675
Omnicell
OMCL
$1.46B
| $803K | ﹤0.01% |
18,029
-245,023
| -93% | -$10.9M |
|